Computational phenotypes for patients with opioid-related disorders presenting to the emergency department.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 28 04 2023
accepted: 31 08 2023
medline: 18 9 2023
pubmed: 15 9 2023
entrez: 15 9 2023
Statut: epublish

Résumé

We aimed to discover computationally-derived phenotypes of opioid-related patient presentations to the ED via clinical notes and structured electronic health record (EHR) data. This was a retrospective study of ED visits from 2013-2020 across ten sites within a regional healthcare network. We derived phenotypes from visits for patients ≥18 years of age with at least one prior or current documentation of an opioid-related diagnosis. Natural language processing was used to extract clinical entities from notes, which were combined with structured data within the EHR to create a set of features. We performed latent dirichlet allocation to identify topics within these features. Groups of patient presentations with similar attributes were identified by cluster analysis. In total 82,577 ED visits met inclusion criteria. The 30 topics were discovered ranging from those related to substance use disorder, chronic conditions, mental health, and medical management. Clustering on these topics identified nine unique cohorts with one-year survivals ranging from 84.2-96.8%, rates of one-year ED returns from 9-34%, rates of one-year opioid event 10-17%, rates of medications for opioid use disorder from 17-43%, and a median Carlson comorbidity index of 2-8. Two cohorts of phenotypes were identified related to chronic substance use disorder, or acute overdose. Our results indicate distinct phenotypic clusters with varying patient-oriented outcomes which provide future targets better allocation of resources and therapeutics. This highlights the heterogeneity of the overall population, and the need to develop targeted interventions for each population.

Identifiants

pubmed: 37713393
doi: 10.1371/journal.pone.0291572
pii: PONE-D-23-12712
pmc: PMC10503758
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0291572

Subventions

Organisme : NIDA NIH HHS
ID : UG1 DA015831
Pays : United States
Organisme : NIDDK NIH HHS
ID : T35 DK104689
Pays : United States

Informations de copyright

Copyright: © 2023 Taylor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA Netw Open. 2021 Feb 1;4(2):e2037259
pubmed: 33587136
BMC Med Inform Decis Mak. 2018 Sep 14;18(Suppl 3):74
pubmed: 30255810
JAMA. 2021 Feb 9;325(6):523
pubmed: 33560330
PLoS One. 2019 Jul 16;14(7):e0219717
pubmed: 31310611
Eur Respir J. 2016 Sep;48(3):683-93
pubmed: 27418553
Drug Alcohol Depend. 2019 Jul 1;200:59-63
pubmed: 31100636
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350
pubmed: 33965972
Anesth Analg. 2017 Nov;125(5):1749-1760
pubmed: 29049119
JMIR Med Inform. 2019 Oct 31;7(4):e15794
pubmed: 31674913
J Biomed Inform. 2019 Jun;94:103185
pubmed: 31028874
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S14-27
pubmed: 12479251
J Clin Epidemiol. 2008 Dec;61(12):1234-1240
pubmed: 18619805
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Ann Emerg Med. 2020 Jan;75(1):13-17
pubmed: 31229387
Artif Intell Med. 2021 Jul;117:102083
pubmed: 34127232
Ann Emerg Med. 2018 Oct;72(4):420-431
pubmed: 29880438
J Urban Health. 2015 Aug;92(4):758-72
pubmed: 26077643
BMC Med Res Methodol. 2015 Oct 23;15:90
pubmed: 26497748
N Engl J Med. 2018 Dec 27;379(26):2485-2487
pubmed: 30586517
JAMA Netw Open. 2022 Jan 4;5(1):e2144955
pubmed: 35076700
Rev Infect Dis. 1988 Jan-Feb;10(1):151-8
pubmed: 3281219
Pain Med. 2018 Mar 1;19(3):485-490
pubmed: 28460060
Subst Abus. 2022;43(1):841-847
pubmed: 35156912
Int J Med Inform. 2021 Dec;156:104621
pubmed: 34673309

Auteurs

R Andrew Taylor (RA)

Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, United States of America.
Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, United States of America.

Aidan Gilson (A)

Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Wade Schulz (W)

Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, United States of America.
Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Kevin Lopez (K)

Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, United States of America.

Patrick Young (P)

Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Sameer Pandya (S)

Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Andreas Coppi (A)

Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

David Chartash (D)

Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, United States of America.
Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, United States of America.
School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland.

David Fiellin (D)

Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Gail D'Onofrio (G)

Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH